Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861728 · ClinicalTrials.gov registry record · NA
Viral Conjunctivitis Treatment Study
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03861728 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 11 participants.
The verdict
NCT03861728, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The objective of this study is to determine the efficacy Avenova® (0.01% hypochlorous acid) in the treatment of viral conjunctivitis. The investigators hypothesize that patients treated with Avenova® will have a quicker resolution of their ocular signs and symptoms of Viral Conjunctivitis compared with artificial tears.
Interventions
- OTHER Placebo
- DEVICE 0.01% Hypochlorous acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2020-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03861728
The ClinicalTrials.gov registry entry for NCT03861728 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03861728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03861728 about?
NCT03861728 is a clinical study titled "Viral Conjunctivitis Treatment Study". The objective of this study is to determine the efficacy Avenova® (0.01% hypochlorous acid) in the treatment of viral conjunctivitis. The investigators hypothesize that patients treated with Avenova® will have a quicker resolution of their ocular signs and symptoms of Viral Conjunctivitis compared w...
What is the current status of trial NCT03861728?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2018-11-14. Estimated completion is 2020-02-08.
What interventions are being tested in trial NCT03861728?
The interventions under investigation include: Placebo (OTHER), 0.01% Hypochlorous acid (DEVICE).
Who is sponsoring clinical trial NCT03861728?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.